Muscle loss may change how anesthesia drugs work in cancer patients
NCT ID NCT07003061
Summary
This study aims to understand if muscle loss (sarcopenia) changes how patients respond to muscle-relaxing drugs used during anesthesia for gastrointestinal cancer surgery. Researchers will observe 100 patients during their operations, comparing those with and without muscle loss. The goal is to gather information that could help anesthesiologists tailor drug doses for safer, more personalized care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea
RECRUITINGAnkara, Yenimahalle, 06200, Turkey (Türkiye)
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.